Natera stock is trading -7.28% below its average target price of $230.89 after marking a 3.9% during today's afternoon session. Analysts are giving the Large-Cap Medical Specialities company an average rating of buy and target prices ranging from $186.0 to $250.0 per share.
The stock has an average amount of shares sold short at 3.0%, and a short ratio of 3.4. The company's insiders own 3.11% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that a significant number of institutional investors are invested in the stock, with 96.0% of Natera's shares being owned by this investor type.
Institutions Invested in Natera
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2025-09-30 | Vanguard Group Inc | 9% | 12,389,033 | $2,652,368,029 |
| 2025-09-30 | Price (T.Rowe) Associates Inc | 9% | 11,947,415 | $2,557,822,033 |
| 2025-09-30 | JPMORGAN CHASE & CO | 8% | 11,628,914 | $2,489,634,155 |
| 2025-09-30 | Blackrock Inc. | 8% | 10,964,351 | $2,347,357,865 |
| 2025-09-30 | Farallon Capital Management LLC | 3% | 4,253,452 | $910,621,523 |
| 2025-09-30 | State Street Corporation | 2% | 3,389,599 | $725,679,237 |
| 2025-09-30 | Duquesne Family Office Llc | 2% | 3,214,532 | $688,199,144 |
| 2025-09-30 | Franklin Resources, Inc. | 2% | 2,665,013 | $570,552,623 |
| 2025-09-30 | Geode Capital Management, LLC | 2% | 2,596,955 | $555,982,086 |
| 2025-09-30 | Wellington Management Group, LLP | 2% | 2,556,062 | $547,227,304 |
Besides an analyst consensus of some upside potential, other market factors point to there being positive market sentiment on Natera.
